{"id":"W2514122689","doi":"10.1186/s12931-016-0425-5","title":"Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review","year":2016,"lang":"en","type":"review","venue":"Respiratory Research","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Pfizer Canada; Novartis Pharma; Grifols; Glenmark Pharmaceuticals; GlaxoSmithKline; Merck Canada; Teva Pharmaceutical Industries; Genentech; AstraZeneca; Pfizer","keywords":"Medicine; Lama; Exacerbation; Bronchodilator; COPD; Bronchiectasis; Bronchodilation; Chronic bronchitis; Azithromycin; Bronchodilator Agents; Intensive care medicine; Bronchitis; Internal medicine; Asthma; Antibiotics; Lung","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.008003434,0.0008363104,0.00321905,0.001954631,0.0003612109,0.000131017,0.001046742,0.0006883527,0.003989978],"category_scores_gemma":[0.00323953,0.0005807871,0.0006956564,0.003625391,0.0007975609,0.0003488003,0.0008182376,0.004105789,0.003242536],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004796903,"about_ca_system_score_gemma":0.01057985,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004861273,"about_ca_topic_score_gemma":0.00002761108,"domain_scores_codex":[0.9838678,0.007727395,0.001609808,0.001958505,0.002974975,0.001861502],"domain_scores_gemma":[0.9938018,0.001856681,0.0003723994,0.001411265,0.001265911,0.001291942],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003449397,0.0003966745,0.00004422765,0.07800877,0.0002968398,0.001017941,0.0001369846,5.723905e-7,0.00007535633,0.0001783049,0.05107901,0.8684204],"study_design_scores_gemma":[0.001100394,0.0005451833,0.0003918765,0.1046095,0.0003105688,0.00004336946,0.0003186471,0.000002778543,0.00001180236,0.0001041433,0.8920716,0.0004901399],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004146435,0.9758451,0.000008113988,0.0006652019,0.0001540758,0.01179676,0.0002733784,0.0000977985,0.01074495],"genre_scores_gemma":[0.00007455778,0.9908183,0.00004507452,0.0002841541,0.000917269,0.004397007,0.00008611532,0.0001575561,0.003219972],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8679302,"threshold_uncertainty_score":0.9996644,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1972340919198312,"score_gpt":0.5132719802528826,"score_spread":0.3160378883330514,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}